Patents Assigned to University of North Carolina at CHapel Hill
  • Patent number: 11691995
    Abstract: The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: July 4, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Mark H. Schoenfisch, Jae Ho Shin, Nathan Stasko
  • Patent number: 11672818
    Abstract: Disclosed herein are cyclodextrin molecules covalently modified to store and release nitric oxide, as well as methods of making and uses thereof. The covalently modified cyclodextrin molecules may be tailored, in several embodiments, to release nitric oxide in a controlled manner and are useful for reduction and/or eradication of bacteria and for the treatment of disease.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: June 13, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Mark H. Schoenfisch, Haibao Jin
  • Patent number: 11667733
    Abstract: Disclosed herein are isotactic polyvinyl ethers and improved methods of making same. The method disclosed herein can produce polyvinyl ethers having a higher isotacticity as compared to polyvinyl ethers prepared with conventional methods.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: June 6, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Frank Liebfarth, Aaron Teator
  • Patent number: 11642313
    Abstract: The presently disclosed subject matter describes the use of fluorinated elastomer-based materials, in particular perfluoropolyether (PFPE)-based materials, in high-resolution soft or imprint lithographic applications, such as micro- and nanoscale replica molding, and the first nano-contact molding of organic materials to generate high fidelity features using an elastomeric mold. Accordingly, the presently disclosed subject matter describes a method for producing free-standing, isolated nanostructures of any shape using soft or imprint lithography technique.
    Type: Grant
    Filed: November 11, 2020
    Date of Patent: May 9, 2023
    Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
    Inventors: Joseph M. DeSimone, Jason P. Rolland, Benjamin W. Maynor, Larken E. Euliss, Ginger Denison Rothrock, Ansley E. Dennis, Edward T. Samulski, R. Jude Samulski
  • Patent number: 11639509
    Abstract: Disclosed herein are methods and compositions comprising an adeno-associated virus 2.5 (AAV2.5) capsid protein, comprising one or more amino acids substitutions, (e.g., which does not contain a substitution at the position corresponding to amino acid 267 of AAV2.5, or does not contain a serine at the position corresponding to amino acid 267 of AAV2.5) wherein the substitutions introduce a new glycan binding site into the AAV capsid protein.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: May 2, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventor: Richard Jude Samulski
  • Patent number: 11640682
    Abstract: A method for processing digital subtraction angiography (DSA) or computed tomography (CT) images for reduced radiation exposure to a DSA or CT subject includes receiving, as input, a plurality of captured DSA or CT image frames of a contrast agent flowing through a volume of interest in a subject. The method further includes fitting a mathematical model to measured contrast agent density of individual voxels of the captured DSA or CT image frames to produce a mathematical model of contrast agent flow across the captured DSA or CT image frames. The method further includes sampling the mathematical model of contrast agent flow for the individual voxels to produce reconstructed DSA or CT image frames. The method further includes outputting at least one of the reconstructed CT or DSA image frames.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: May 2, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Andrew Lateef Abumoussa, Yueh Zenas Lee
  • Patent number: 11635407
    Abstract: Methods, systems and devices that allow independently applied pressures to a BGE reservoir and a sample reservoir for pressure-driven injection that can inject a discrete sample plug into a separation channel that does not require voltage applied to the sample reservoir and can allow for in-channel focusing methods to be used. The methods, systems and devices are particularly suitable for use with a mass spectrometer.
    Type: Grant
    Filed: August 3, 2020
    Date of Patent: April 25, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: John Scott Mellors, Erin Anne Redman, John Michael Ramsey
  • Patent number: 11633424
    Abstract: Chondroitin sulfate compounds comprising chondroitin sulfate backbone 19 mer, CS-A 19 mer, CS-C 19 mer, CS-E 19 mer, C8 backbone 13 mer, C8-A 13 mer, CS-C 13 mer, CS-E 13 mer and/or combinations thereof are provided. Methods of treating histone toxicity in a subject are provided, the methods including administering to a subject a chondroitin sulfate compound to treat the histone toxicity in the subject. Pharmaceutical compositions for use in treating histone toxicity and/or sepsis are provided. Methods of treating sepsis in a subject are provided, the methods including administering to a subject a chondroitin sulfate compound to treat the sepsis in the subject.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: April 25, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Jian Liu, Jine Li, Guowei Su, Rafal Pawlinski, Erica Sparkenbaugh
  • Patent number: 11634404
    Abstract: The disclosure of a compound of Formula (I) or a pharmaceutically acceptable salt thereof (I) The variables W, R1, R2, R3, and R4 are defined in the disclosure. The disclosure provides a compound or salt of Formula (I) together with a pharmaceutically acceptable carrier. The disclosure also provides methods of treating a patient for Parkinson's disease and related syndromes, dyskinesia, especially dyskinesias secondary to treating Parkinson's disease with L-DOPA, neurodegenerative disorders such as Alzheimer's disease and dementia, Huntington's disease, restless legs syndrome, bipolar disorder and depression, schizophrenia, cognitive dysfunction, or substance use disorders, the methods comprising administering a compound of Formula I or salt thereof to the patient. The disclosure provides combination methods of treatment in which the compound of Formula (I) is administered to the patient together with one or more additional active agents.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: April 25, 2023
    Assignees: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE UNIVERSITY OF KANSAS, THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
    Inventors: David R. Sibley, Amy Elizabeth Moritz, R. Benjamin Free, Joseph P. Steiner, Noel Terrence Southall, Marc Ferrer, Xin Hu, Warren S. Weiner, Jeffrey Aubé, Kevin Frankowski
  • Patent number: 11617788
    Abstract: Viral promoters and compositions and methods of use thereof are provided. Compositions include viruses with impaired ability to reactivate from latency, and pharmaceutical compositions and method of use thereof. The genome of the viruses include one or more mutations that reduce expression from one or more promoters that regulate expression of viral genes during reactivation from latency. The mutation(s) are typically in a region of the viral genome that includes (i) promoter elements of the iP1 promoter of human cytomegalovirus, or the sequence of another virus corresponding thereto (e.g., an iP1 promoter homolog); (ii) promoter elements of the iP2 promoter of human cytomegalovirus, or sequence of another virus corresponding thereto (e.g., an iP2 promoter homolog); or (iii) a combination thereof. In some embodiments the virus encodes one or more heterologous antigens. The viruses can be used as vaccines to induce prophylactic and therapeutic immune responses in subjects in need thereof.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: April 4, 2023
    Assignees: Arizona Board of Regents on Behalf of The University of Arizona, The University of North Carolina at Chapel Hill, The Board of Supervisors of Louisiana State University and Agricultura and Mechanical Colleae
    Inventors: Felicia Goodrum, Nathaniel Moorman, Jeremy Kamil
  • Patent number: 11613547
    Abstract: In some aspects, the present disclosure provides compounds of the formula: wherein the variables are as defined herein. In some embodiments, these compounds may be used to reduce the pain of a patient. These compounds may be used in pain relief and show an improved pharmaceutical profile relative to other commonly used opiates and opioid derivatives.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: March 28, 2023
    Assignees: University of Health Sciences & Pharmacy in St. Louis, University of Southern California, The University of North Carolina at Chapel Hill, Memorial Sloan Kettering Cancer Center, University of Florida Research Foundation, Incorporated
    Inventors: Susruta Majumdar, Vsevolod Katritch, Bryan Roth, Jay McLaughlin, Saheem Zaidi, Gavril W. Pasternak, Rajendra Uprety
  • Patent number: 11607197
    Abstract: Systems and methods for measuring micro-architectural properties of vascular networks are described herein. An example method can include injecting an ultrasound contrast agent into a medium, and transmitting a plurality of acoustic pulses into the medium using a ultrasound transducer array. Each respective acoustic pulse can be transmitted from one or more elements of the ultrasound transducer array. The method can also include receiving a plurality of backscattered signals with the ultrasound transducer array in response to each respective acoustic pulse, and obtaining a response matrix including the backscattered signals. The method can further include extracting a coherent or incoherent contribution to the backscattered signals from the response matrix, and quantifying a property of a vascular network based on the coherent or incoherent contribution to the backscattered signals.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: March 21, 2023
    Assignees: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, NORTH CAROLINA STATE UNIVERSITY
    Inventors: Marie Muller, Paul Dayton, Aditya Joshi
  • Patent number: 11604242
    Abstract: Phase-incrementing MRSI (pi-MRSI) method has resolved overlapping biomarker images in the presence of a read-gradient. On a Bruker 9.4T MRI spectrometer, the pi-SEE-HSelMQC sequence was implemented. The choline-selective and lactate CH-selective RF pulses were phase incremented by 10° in opposite signs, synchronized with the phase-encoding steps. The lactate and choline images from a yogurt phantom displayed opposite image offsets without image overlapping. In vivo one-dimensional pi-SEE-HSelMQC CSI images of lactate and choline, acquired from the MDA-MB-231 human breast cancer xenograft in a nude mouse, as well as two-dimensional pi-SEE-HSelMQC imaging of lactate and choline acquired from the PC3 human prostate cancer xenograft in a nude mouse, also had opposite image offsets, shifted away from the spurious residual water signals in the image center. The pi-SEE-HSelMQC method completely suppresses lipid and water with potential clinical applications in disease diagnosis and therapeutic interventions.
    Type: Grant
    Filed: September 20, 2021
    Date of Patent: March 14, 2023
    Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
    Inventor: Qiuhong He
  • Patent number: 11584720
    Abstract: The invention generally relates to methods of making substituted arenes via direct C—H amination. More specifically, methods of making para- and ortho-substituted arenes via direct C—H amination are disclosed. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: February 21, 2023
    Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
    Inventors: David Nicewicz, Nathan Romero, Kaila Margrey, Nicholas Tay
  • Patent number: 11587665
    Abstract: A system for estimating maximum heart rate and maximal oxygen uptake from submaximal exercise intensities can include an exercise intensity monitor, a cardiopulmonary monitor, and one or more computers. The computers can be configured, by virtue of appropriate programming, to receive submaximal exercise intensity data from the exercise intensity monitor and submaximal cardiopulmonary data from the cardiopulmonary monitor while a user, who coupled to the exercise intensity monitor and the cardiopulmonary monitor, is performing an exercise at a submaximal exercise intensity. The one or more computers then determine a heuristic estimate of a maximal cardiopulmonary state of the user based on the submaximal exercise intensity data and the submaximal cardiopulmonary data.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: February 21, 2023
    Assignees: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, DUKE UNIVERSITY
    Inventors: Claudio Luiz Battaglini, Brian Patrick Mann, Michael Joseph Mazzoleni
  • Publication number: 20230033473
    Abstract: A system, mixing-enhanced microfluidic container, and methods for small volume sample collection and/or analysis is disclosed. Namely, the invention is directed to a small volume sample collection system that includes a mixing-enhanced microfluidic container and a durable reusable actuation chuck. The mixing-enhanced microfluidic container is used to collect small volumes of sample fluid and includes a means for mixing the sample fluid with reagents disposed within the microfluidic container. The mixing means utilize an array of surface-attached structures (e.g., a micropost array). The application of an “actuation force,” such as a magnetic or electric field, actuates the surface-attached structures into movement, wherein the actuation chuck in close proximity to the mixing-enhanced microfluidic container provides the “actuation force.
    Type: Application
    Filed: October 10, 2022
    Publication date: February 2, 2023
    Applicants: Redbud Labs, Inc., THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
    Inventors: Richard Chasen Spero, Jay Kenneth Fisher, Richard Superfine
  • Patent number: 11566050
    Abstract: The present invention is directed to methods and compositions for norovirus therapeutics, such as vaccines, and diagnostics.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: January 31, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Lisa Chon Lindesmith, Ralph Steven Baric, Kari Moore Debbink, Eric Francis Donaldson
  • Patent number: 11566213
    Abstract: A microfabricated device having at least one gas-entrapping feature formed therein in a configuration that entraps air bubbles upon wetting the feature with a solvent or solution is described. The device includes a sacrificial residue in contact with the gas-entrapping feature, the dissolution of which guides the wetting of the gas-entrapping feature.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: January 31, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Nancy L. Allbritton, Yuli Wang, Christopher Sims
  • Patent number: 11560418
    Abstract: The present invention provides Factor IX fusion proteins with higher specific activity and a longer useful clotting function relative to wild type or non-modified Factor IX protein.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: January 24, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventor: Tal Kafri
  • Patent number: 11547765
    Abstract: This invention relates to polynucleotides encoding mini-dystrophin proteins, viral vectors comprising the same, and methods of using the same for delivery of mini-dystrophin to a cell or a subject.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: January 10, 2023
    Assignees: The University of North Carolina at Chapel Hill, Bamboo Therapeutics, Inc.
    Inventors: Xiao Xiao, Juan Li, Chunping Qiao, Scott W. J. McPhee, Richard J. Samulski, Maritza McIntyre